INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
AJ
Anders JackChief Financial Officer
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$796K
3,992 sh
Sep 16, 2026Sep 18, 2026
Page 327 of 1689
← PrevNext →
traded Sep 16, 2026
+2d
SEC Form 4

Evidence

26
IA
Imberman AlanCFO and Treasurer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$773K
76.5K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

26
FD
Fortunato DavidDirector, CEO and President
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$507K
50.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

26
BM
Bartolucci Ryan MChief Accounting Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
7,062 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

26
VL
von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner
DUOLDuolingo, Inc.
Open-market sale · 10b5-1 plan
SELL$4.10M
27.3K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

26
ZR
Zage George Raymond IIIDirector, 10% Owner
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$5.21M
333.6K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

25
WM
Wong-Zaza MelvinaDirector
KRNYKearny Financial Corp.
Open-market purchase
BUY$15K
1,560 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

25
MM
Mink Brook Asset Management LLC10% Owner
DLHCDLH Holdings Corp.
Open-market purchase
BUY$1,241
316 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

25
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$155K
1,648 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

25
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$148K
1,525 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

25
RL
Roger LisaFormer Chief Financial Officer
BRFHBARFRESH FOOD GROUP INC.
Open-market sale
SELL$28K
25.3K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

25
MM
Mink Brook Asset Management LLC10% Owner
DLHCDLH Holdings Corp.
Open-market purchase
BUY$807
204 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

24
KA
Kramer Andrea AnigatiChief Operating Officer, 10% Owner
HLNEHamilton Lane INC
Grant or award
A$1,809
27 sh
Jun 30, 2026Sep 18, 2026
traded Jun 30, 2026
+80dSEC Form 4

Evidence

24
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$77K
1,800 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

24
CT
Carl Drew ThomasChief Accounting Officer
HLNEHamilton Lane INC
Grant or award
A$5,227
78 sh
Jun 30, 2026Sep 18, 2026
traded Jun 30, 2026
+80dSEC Form 4

Evidence

24
AM
Alberti-Perez MilenaDirector
SCHLSCHOLASTIC CORP
Grant or award
A$130K
3,700 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

24
SS
Sanfrey Jeffrey ScottChief Operating Officer
BLBDBlue Bird Corp
Open-market sale
SELL$250K
4,000 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

24
WC
Wolff Anne ClarkeDirector
SCHLSCHOLASTIC CORP
Grant or award
A$130K
3,700 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

24
BM
Blitzer MichaelDirector
MRLNMerlin, Inc.
Other acquisition or disposition
J—
262.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

23
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
336 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

23
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$2.64M
30.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

22
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$14K
148 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
TS
Teter Timothy S.EVP, General Counsel and Sec
NVDANVIDIA CORP
Tax withholding
F$7.58M
35.7K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
KM
Kumar MukulPRESIDENT, ENGINEERING
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$134K
8,000 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$52K
541 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$55K
586 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
PS
Padisetty SivaprasadChief Technology Officer
GTLBGitlab Inc.
Tax withholding
F$1.51M
30.9K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$144K
1,470 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$107K
1,079 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
RP
Ross Jessica PChief Financial Officer
GTLBGitlab Inc.
Tax withholding
F$1.59M
32.6K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$348K
1,747 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

22
FD
Fortunato DavidDirector, CEO and President
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$507K
50.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

22
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$264K
26.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
MC
McKee CharlotteCMO and Head of R&D
SIONSionna Therapeutics, Inc.
Grant or award
A—
50.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
SM
Stetter MarkDirector
ZTSZoetis Inc.
Grant or award
A$25K
342 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
MC
McKee CharlotteCMO and Head of R&D
SIONSionna Therapeutics, Inc.
Grant or award
A—
50.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
EB
Epperly Melissa B,Director
ROIVRoivant Sciences Ltd.
Grant or award
A—
5,054 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

21
RE
Ridloff ElenaCFO and CBO
SIONSionna Therapeutics, Inc.
Grant or award
A—
47.3K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
RE
Ridloff ElenaCFO and CBO
SIONSionna Therapeutics, Inc.
Grant or award
A—
47.3K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

21
LA
Lumpkin AlexandraChief Legal Officer
REAXReal REMAX Group Inc.
Option exercise
M—
302 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence